In conclusion, mTOR inhibitors have a high potential to modulate inflammation in cardiovascular disorders by breaking the vicious cycle of autonomously maintained inflammation and boosting tolerance mechanisms. This evidence concerns the gene MTOR and cardiovascular disorder.